Tag Archives: HIV

FDA Relaxes Blood Donation Ban For Gay Men Again, STILL Stigmatizing To Some.

FDA Relaxes Blood Donation Ban For Gay Men Again, STILL Stigmatizing To Some.

Despite the fact that every drop of blood donated is tested for every disease including AIDS and other diseases the FDA has demonized and stigmatized gay men for decades.

The Food and Drug Administration on Thursday announced it had officially eliminated SOME restrictions that had previously prohibited many blood donations by gay and bisexual men from giving blood.

In a news release, the agency said it will recommend a series of “individual risk-based questions” that will be the same for every blood donor, regardless of their sexual orientation, gender or sex. Those who have had anal sex with a new sexual partner, or more than one sexual partner, within the last three months would be asked to wait to donate blood.

With the updated guidelines, most gay and bisexual men who are in a monogamous relationship with a man will no longer have to refrain from sex in order to donate blood. With the EXCEPTION of anyone taking HIV medications — including people who are HIV negative who are taking medications called PrEP to prevent infection.

The original blood donation ban, which was implemented in the 1980s during the height of the HIV/AIDS epidemic, prohibits men who have had sex with other men (MSM) from donating blood for 12 months after their last sexual encounter. In 2020, the ban was revised to reduce the deferral period to three months.

In the past the American Medical Association, the American Red Cross, and numerous other health organizations have called for the ban to be lifted entirely, as it is not based on scientific evidence but the FDA has always ignored them

For decades the FDA policy perpetuated a harmful stereotypes that stigmatize and discriminated against gay and bisexual men. . It implied that all are inherently diseased and dangerous, and reinforced the hate of anti-gay activist and the notion that gay men were they less worthy of donating blood than their heterosexual counterparts.

Still not there yet.

Federal Judge Blocks PrEP Coverage Under Affordable Care Act- "Obamacare"

Federal Judge Blocks PrEP Coverage Under Affordable Care Act- “Obamacare”

A federal judge in Texas (of course) on Thursday blocked the Affordable Care Act aka Obamacare’s mandate that health insurance plans cover preventive care against HIV (PrEP), at no cost to patients.

U.S. District Judge Reed O’Connor a Republican appointed by George Bush in Fort Worth, Texas, previously found that the PrEP mandate violated a federal religious freedom law and that other no-cost preventive care mandates were based on recommendations by an illegally appointed task force. Now the judge has now blocked the federal government from enforcing the mandates.

The legal challenge was brought by eight individuals and two businesses, all from Texas. They argued that the free PrEP requirement requires business owners and consumers to pay for services that “encourage homosexual behavior, prostitution, sexual promiscuity and intravenous drug use” despite their religious beliefs.

The conservative America First Legal Foundation is helping to represent the plaintiffs. The group was founded by neo-Nazi Stephen Miller, who served as an adviser to Republican President Donald Trump.

American Medical Association President Jack Resneck called it “deeply flawed” and said that patients “will be subjected to needless illness and preventable deaths” as a result.

A month’s supply of Truvada is nearly $2,000 without insurance .

FDA Approves Twice-yearly HIV Treatment Sunlenca

FDA Approves Twice-yearly HIV Treatment Sunlenca

On December 22, the Federal Food and Drug Administration approved Gilead Sciences’ Sunlenca (lenacapavir), offering hope for heavily treatment-experienced individuals.

Via EDGE: Sunlenca, the first HIV capsid inhibitor, is indicated for people who are unable to maintain an undetectable viral load on their current antiretroviral regimen due to resistance, intolerance, or safety considerations. This group includes long-term survivors who may have used early HIV drugs one at a time or in suboptimal combinations. This approval does not include first-time HIV treatment, but ongoing studies show Sunlenca also looks promising for that indication. “Today’s approval ushers in a new class of antiretroviral drugs that may help patients with HIV who have run out of treatment options,” Dr. Debra Birnkrant, director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research, said in an agency press release. “The availability of new classes of antiretroviral medications may possibly help these patients live longer, healthier lives.”

Previously, the longest-acting treatment was ViiV Healthcare’s Cabenuva (injectable cabotegravir and rilpivirine), which can be administered every one or two months. 

Continue reading FDA Approves Twice-yearly HIV Treatment Sunlenca